Production (Stage)
Outlook Therapeutics, Inc.
OTLK
$1.90
$0.031.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.56M | 5.70M | 14.93M | 32.02M | 47.23M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 3.60M | 3.11M | -- | -- | -- |
| Prepaid Expenses | 6.65M | 6.86M | 12.49M | 13.59M | 10.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.81M | 15.67M | 27.42M | 45.62M | 57.79M |
|
|
|||||
| Total Current Assets | 17.81M | 15.67M | 27.42M | 45.62M | 57.79M |
| Net Property, Plant & Equipment | 250.70K | 262.80K | 274.60K | 286.50K | 3.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 393.80K | 416.00K | 439.30K | 479.20K | 473.20K |
| Total Assets | 19.08M | 17.01M | 28.82M | 47.09M | 59.03M |
|
|
|||||
| Total Accounts Payable | 7.77M | 12.19M | 7.97M | 5.55M | 4.36M |
| Total Accrued Expenses | 3.15M | 3.39M | 3.24M | 2.68M | 3.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.05M | 30.80M | 29.49M | 32.46M | 44.75M |
| Total Finance Division Other Current Liabilities | 1.86M | 1.86M | 1.86M | 1.86M | 1.86M |
| Total Other Current Liabilities | 1.86M | 1.86M | 1.86M | 1.86M | 1.86M |
| Total Current Liabilities | 24.82M | 48.24M | 42.55M | 42.55M | 54.08M |
|
|
|||||
| Total Current Liabilities | 24.82M | 48.24M | 42.55M | 42.55M | 54.08M |
| Long-Term Debt | 21.05M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 219.00K | 233.10K | 246.90K | 260.40K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.45M | 18.83M | 59.10M | 87.95M | 139.18M |
| Total Liabilities | 51.54M | 67.30M | 101.90M | 130.77M | 193.26M |
|
|
|||||
| Common Stock & APIC | 539.80M | 475.62M | 470.21M | 465.30M | 459.15M |
| Retained Earnings | -572.26M | -525.91M | -543.28M | -548.98M | -593.39M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -32.46M | -50.29M | -73.08M | -83.67M | -134.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.46M | -50.29M | -73.08M | -83.67M | -134.24M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.46M | -50.29M | -73.08M | -83.67M | -134.24M |
|
|
|||||